Patent ID: 7314865

Claim:
A pharmaceutical composition comprising a peptide having the formula Xaa 1 -Xaa 2 -Xaa 3 -Xaa 4 -Xaa 5 -Xaa 6 -Xaa 7 -Xaa 8 -X-Z, or a pharmaceutically acceptable salt thereof, wherein: Xaa 1 is a glutamine residue; Xaa 2 is one of a leucine residue, an isoleucine residue, a valine residue, a phenylalanine residue, and a tyrosine residue; Xaa 3 is one of an asparagine residue and a threonine residue; Xaa 4 is one of a phenylalanine residue and a tyrosine residue; Xaa 5 is one of a threonine residue and a serine residue; Xaa 6 is one of a proline residue, a serine residue, a threonine residue, and an alanine residue; Xaa 7 is one of a glycine residue, an asparagine residue, a serine residue, an aspartate residue, a valine residue, and a tryptophan residue; Xaa 8 is a tryptophan residue; X is from 0 to 10 amino acid residues; and Z is one of a hydrogen radical and a carboxyl terminus-blocking moiety.